(Photo credit: Library of Congress) In honour of Black History Month, we are pleased to feature a series of stories celebrating the contributions Black individuals have made to our understanding of infectious diseases and how to prevent and treat them. Each story is...
December 7, 2023 By Betty Zou The Emerging and Pandemic Infections Consortium, along with partners bioMérieux Canada, the AMR – One Health Consortium and the Association of Medical Microbiology and Infectious Disease Canada (AMMI Canada), recently co-hosted the second...
Subha Dahal (left) and Alice Zhabokritsky December 1, 2023 By Betty Zou Over four decades after the start of the AIDS epidemic, researchers in the Emerging and Pandemic Infections Consortium are reshaping approaches to target the human immunodeficiency virus (HIV)...
(Photo by Roberto Sorin on Unsplash) November 23, 2023 By Betty Zou Earlier this year, the federal government released its Pan-Canadian Action Plan on Antimicrobial Resistance, which details federal, provincial and territorial commitments to address antimicrobial...
Leah Cowen (left) and Jennie Johnstone November 20, 2023 By Betty Zou We may not need to worry about the zombie fungus in the hit HBO television series The Last of Us but there is another real-life fungal pathogen that we should be paying close attention to. Candida...
As cold and flu season approaches, Canadians are facing respiratory syncytial virus (RSV), an increase in COVID-19 activity, and influenza — but also have new options to protect their health. To learn more, we spoke with Shelly Bolotin, director of the Centre for Vaccine Preventable Diseases, Shaun Morris, a pediatric infectious disease physician at the Hospital for Sick Children, and Allison McGeer, an infectious disease specialist at Toronto’s Sinai Health.
According to the World Health Organization’s World Malaria Report 2022, 247 million people fell ill with malaria in 2021. In the same year, there were an estimated 619,000 deaths due to the disease, with three out of four deaths in children aged under five. With the right prevention tools and treatments, the WHO’s ambitious targets of reducing global malaria incidence and mortality rates by at least 90% by 2030 can become reality and accelerate progress towards eradication. Getting there requires innovations that have been purposely designed with implementation and impact in mind. Through their work on new diagnostics, vaccines and treatments, EPIC members are doing just that.
Tuberculosis (TB) remains one of the world’s most deadly infectious threats and a significant global health challenge. The World Health Organization estimates that in 2021, 10.6 million people became sick with the disease and 1.6 million people died of TB, which is both preventable and curable. Learn more about how members of the University of Toronto’s Emerging and Pandemic Infections Consortium are working to tackle TB from multiple angles, from creating better vaccines to gaining a deeper understanding of TB’s financial toll on patients and families.
Related page →
Link to resource →
Contact us CTA →